Skip to content

TMC-125 and darunavir show strong effect in highly treatment-experienced, even without T-20

Thai programme demonstrates HIV services can be successfully delivered in prison

Brazil: Kaletra price cut agreed as generic efavirenz arrives

Infant ARV treatment study shows advantage for immediate treatment

Risk of viral rebound decreases with longer treatment, even with previous failures

Watch your HIV epidemic closely, warns World Bank scientist, or risk pointless prevention work

Different neurological problems affecting people with HIV in the era of HAART

Brain-penetrating ARVs not always necessary for control of HIV in the brain?

HIV in the brain — less of a worry in the HAART era or a ticking time bomb?